We have focused on the correlation between the subcellular localization of maspin expression and clinicopathological variables, especially patient prognoses in several cancer types, including LUSC, LUAD, breast cancer, pancreatic cancer, and oral SCC [16,17,18]. Here, SERPINB5 is linked to breast carcinoma.